1,879
Views
2
CrossRef citations to date
0
Altmetric
Case Report

Creutzfeldt–Jakob disease in pregnancy: the use of modified RT-QuIC to determine infectivity in placental tissues

, , , , , & show all
Pages 107-111 | Received 31 Mar 2021, Accepted 19 May 2021, Published online: 16 Jun 2021

References

  • Ladogana A, Puopolo M, Croes EA, et al. Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia, and Canada. Neurology. 2005;64(9):1586–1591.
  • Uttley L, Carroll C, Wong R, et al. Creutzfeldt-Jakob disease: a systematic review of global incidence, prevalence, infectivity, and incubation. Lancet Infect Dis. 2020;20(1):e2–e10.
  • Xiao X, Miravalle L, Yuan J, et al. Failure to detect the presence of prions in the uterine and gestational tissues from a Gravida with Creutzfeldt-Jakob disease. Am J Pathol. 2009;174(5):1602–1608.
  • Bernoulli C, Siegfried J, Baumgartner G, et al. Danger of accidental person-to-person transmission of Creutzfeldt-Jakob disease by surgery. Lancet. 1977;309(8009):478–479.
  • Tamai Y, Kojima H, Kitajima R, et al. Demonstration of the transmissible agent in tissue from a pregnant woman with Creutzfeldt-Jakob disease. N Engl J Med. 1992;327(9):649.
  • Lane KL, Brown P, Howell DN, et al. Creutzfeldt-Jakob disease in a pregnant woman with an implanted dura mater graft. Neurosurgery. 1994;34(4):737–740. discussion 739-40.
  • Di Gangi S, Bertin M, Noventa M, et al. Obstetric dilemma on the most appropriate management of Creutzfeldt-Jakob disease in pregnancy: seventh case presentation, literature review and new insight. J Matern Fetal Neonatal Med. 2015;28(3):254–261.
  • Sperling R, Haak K, Hesson D, et al. Creutzfeldt-Jakob disease in the obstetric patient. J Obstet Gynecol Neonatal Nurs. 2005;34(5):546–550.
  • Dalmas AF, Pougeoise M, Hélou N, et al. [Anaesthetic management for caesarean delivery and Creutzfeldt-Jakob disease]. Ann Fr Anesth Reanim. 2010;29(11):815–817.
  • Nalls AV, McNulty E, Hoover CE, et al. Infectious prions in the pregnancy microenvironment of chronic wasting disease-infected Reeves’ Muntjac Deer. J Virol. 2017;91(15):e00501-17.
  • Orru CD, Groveman BR, Hughson AG, et al. RT-QuIC assays for prion disease detection and diagnostics. Methods Mol Biol. 2017;1658:185–203.
  • Hermann P, Laux M, Glatzel M, et al. Validation and utilization of amended diagnostic criteria in Creutzfeldt-Jakob disease surveillance. Neurology. 2018;91(4):e331–e338. e331-e338.
  • Head MW, Ironside JW. Review: Creutzfeldt-Jakob disease: prion protein type, disease phenotype and agent strain. Neuropathol Appl Neurobiol. 2012;38(4):296–310.
  • Wilham JM, Orrú CD, Bessen RA, et al. Rapid end-point quantitation of prion seeding activity with sensitivity comparable to bioassays. PLoS Pathog. 2010;6(12):e1001217.
  • Denkers ND, Telling GC, Hoover EA. Minor oral lesions facilitate transmission of chronic wasting disease. J Virol. 2011;85(3):1396–1399.
  • Haley NJ, Van de Motter A, Carver S, et al. Prion-seeding activity in cerebrospinal fluid of deer with chronic wasting disease. PLoS One. 2013;8(11):e81488.
  • McNulty EE, Nalls AV, Xun R, et al. In vitro detection of haematogenous prions in white-tailed deer orally dosed with low concentrations of chronic wasting disease. J Gen Virol. 2020;101(3):347–361.